Global Clinical Trial Biorepository and Archiving Solutions Market Report and Forecast 2023-2031

Global Clinical Trial Biorepository and Archiving Solutions Market Report and Forecast 2023-2031


Global Clinical Trial Biorepository and Archiving Solutions Market Outlook

The global clinical trial biorepository and archiving solutions market was valued at USD 3.91 billion in 2022, driven by the increasing complexity of clinical trials across the globe. The market size is anticipated to grow at a CAGR of 8.99% during the forecast period of 2023-2031 to achieve a value of USD 8.46 billion by 2031.

Introduction

Clinical trial biorepository and archiving solutions play a crucial role in the storage, management, and preservation of biological samples and associated data collected during clinical trials. These solutions ensure the integrity and traceability of samples, facilitating research and development of new therapies and treatments. This market introduction provides an overview of the clinical trial biorepository and archiving solutions market and highlights key trends shaping its growth.

The global market for clinical trial biorepository and archiving solutions is witnessing significant growth due to several factors. Firstly, the increasing number of clinical trials and the growing complexity of biomedical research have led to a surge in the volume of biological samples generated. Biorepositories provide the necessary infrastructure and expertise to store and manage these samples, ensuring their long-term preservation for future analysis.

Key Trends in the Clinical Trial Biorepository and Archiving Solutions Market

Key trends in the clinical trial biorepository and archiving solutions market include:
  • Adoption of automation and robotics: The integration of automated systems and robotics in biorepositories has gained traction. These technologies streamline sample handling, storage, and retrieval processes, minimizing human errors and improving operational efficiency.
  • Increasing use of cloud-based storage: Cloud-based storage solutions offer scalability, flexibility, and cost-effectiveness in managing large volumes of data generated from clinical trials. They provide secure and centralized access to data, facilitating collaboration and data sharing among researchers.
  • Implementation of blockchain technology: Blockchain technology is being explored for enhancing data security, integrity, and traceability in biorepositories. It ensures transparency and immutability of data, providing a reliable and auditable record of sample custody, consent, and data access.
Clinical Trial Biorepository and Archiving Solutions Market Segmentations

Market Breakup by Products
  • Preclinical Products
  • Clinical Products
Market Breakup by Phase
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
Market Breakup by Services
  • Biorepository Services
  • Archiving Services
  • Others
Market Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Clinical Trial Biorepository and Archiving Solutions Market Overview

The market for clinical trial biorepository and archiving solutions plays a crucial role in supporting biomedical research and drug development. Biorepositories serve as repositories for biological samples collected during clinical trials, storing them in a secure and controlled environment. These samples, including blood, tissue, and other biomaterials, provide valuable resources for researchers to study diseases, develop new therapies, and advance personalized medicine.

The demand for clinical trial biorepository and archiving solutions is driven by several factors. First, the increasing complexity of clinical trials and the growing need for precise biomarker analysis require efficient sample management and storage systems. Biorepositories provide the infrastructure and expertise to handle large volumes of samples and ensure their quality and integrity throughout the trial process.

Overall, the market for clinical trial biorepository and archiving solutions is poised for growth as the demand for high-quality samples, data integrity, and regulatory compliance continues to increase. Biorepositories that offer comprehensive solutions, incorporating advanced technologies and ensuring the highest standards of quality and security, will play a crucial role in advancing medical research and therapeutic development.

Clinical Trial Biorepository and Archiving Solutions Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Azenta U.S., Inc.
  • Thermo Fisher Scientific Inc. (Patheon)
  • Precision for Medicine, Inc.
  • Medpace
  • ATCC
  • Q2 Solutions
  • Labconnect
  • Charles River Laboratories
  • Cell&Co
  • LabCorp Drug Development
*We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

*Please Note:* The report will take 7 business days to complete, after order confirmation.


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Clinical Trial Biorepository and Archiving Solutions Market Overview
3.1 Global Clinical Trial Biorepository and Archiving Solutions Market Historical Value (2016-2022)
3.2 Global Clinical Trial Biorepository and Archiving Solutions Market Forecast Value (2023-2031)
4 Global Clinical Trial Biorepository and Archiving Solutions Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.3 Porter’s Five Forces Model
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Global Clinical Trial Biorepository and Archiving Solutions Market Segmentation
5.1 Global Clinical Trial Biorepository and Archiving Solutions Market by Products
5.1.1 Market Overview
5.1.2 Preclinical Products
5.1.3 Clinical Products
5.2 Global Clinical Trial Biorepository and Archiving Solutions Market by Phase
5.2.1 Market Overview
5.2.2 Phase I
5.2.3 Phase II
5.2.4 Phase III
5.2.5 Phase IV
5.3 Global Clinical Trial Biorepository and Archiving Solutions Market by Services
5.3.1 Market Overview
5.3.2 Biorepository Services
5.3.3 Archiving Servic es
5.3.4 Others
5.4 Global Clinical Trial Biorepository and Archiving Solutions Market by Region
5.4.1 Market Overview
5.4.2 North America
5.4.3 Europe
5.4.4 Asia Pacific
5.4.5 Latin America
5.4.6 Middle East and Africa
6 North America Clinical Trial Biorepository and Archiving Solutions Market
6.1 Market Share by Country
6.2 United States of America
6.3 Canada
7 Europe Clinical Trial Biorepository and Archiving Solutions Market
7.1 Market Share by Country
7.2 United Kingdom
7.3 Germany
7.4 France
7.5 Italy
7.6 Others
8 Asia Pacific Clinical Trial Biorepository and Archiving Solutions Market
8.1 Market Share by Country
8.2 China
8.3 Japan
8.4 India
8.5 ASEAN
8.6 Australia
8.7 Others
9 Latin America Clinical Trial Biorepository and Archiving Solutions Market
9.1 Market Share by Country
9.2 Brazil
9.3 Argentina
9.4 Mexico
9.5 Others
10 Middle East and Africa Clinical Trial Biorepository and Archiving Solutions Market
10.1 Market Share by Country
10.2 Saudi Arabia
10.3 United Arab Emirates
10.4 Nigeria
10.5 South Africa
10.6 Others
11 Regulatory Framework
11.1 Regulatory Overview
11.1.1 US FDA
11.1.2 EU EMA
11.1.3 INDIA CDSCO
11.1.4 JAPAN PMDA
11.1.5 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Clinical Trials Analysis
14.1 Analysis by Trial Registration Year
14.2 Analysis by Trial Status
14.3 Analysis by Trial Phase
14.4 Analysis by Therapeutic Area
14.5 Analysis by Geography
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Azenta U.S., Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Thermo Fisher Scientific Inc. (Patheon)
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Precision for Medicine, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Medpace
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 ATCC
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Q2 Solutions
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Labconnect
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Charles River Laboratories
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Cell&Co
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 LabCorp Drug Development
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings